A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
N
Shared by NobleBlocks on Mar 1, 2011 • 12:00 AM UTC
Authors:
A. Novotna
,
J. Mares
,
S. Ratcliffe
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex<sup>®</sup>), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis | NobleBlocks
